Company / Free Cash Flow per Share
IDEAYA Biosciences, Inc. Free Cash Flow per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.85
FY2025
5-year range
-$3.87 / $1.43
FY2021-FY2025
Trend
+78.0%
vs FY2024
Sector context
#96 of 192
Health Care
What the data says
At $-0.85, IDEAYA Biosciences, Inc.'s free cash flow per share ranks #96 of 192 in the Health Care sector. Free Cash Flow per Share returned to growth in FY2025 after 2 years of decline, reaching $-0.85.
Based on SEC 10-K filings.
-0.85 in FY2025.
Improved from $-2.44 to $-0.85 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#96 of 192 in Health CareTop 50% of 192This company -$0.85 Sector average $3.32
▼
-125.6% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 78.0% year-over-year.
- Ranks #96 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2022.
- Lowest free cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.85 | +78.0% |
| FY2024 | -$3.87 | -58.4% |
| FY2023 | -$2.44 | -271.0% |
| FY2022 | $1.43 | +203.6% |
| FY2021 | -$1.38 | +4.5% |
| FY2020 | -$1.44 | +55.7% |
| FY2019 | -$3.25 | +89.4% |
| FY2018 | -$30.67 | -52.5% |
| FY2017 | -$20.11 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026